BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7493752)

  • 21. Antiestrogens affect both pathways of killer cell-mediated oncolysis.
    Haeryfar SM; Nagy E; Baral E; Krepart G; Lotocki R; Berczi I
    Anticancer Res; 2000; 20(3A):1849-53. PubMed ID: 10928117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PELs and the perforin and granzyme independent mechanism of CTL-mediated lysis.
    Berke G
    Immunol Rev; 1995 Aug; 146():21-31. PubMed ID: 7493754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
    J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xenospecific cytotoxic T lymphocytes: potent lysis in vitro and in vivo.
    Smyth MJ; Kershaw MH; Trapani JA
    Transplantation; 1997 Apr; 63(8):1171-8. PubMed ID: 9133481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Debate: the mechanism of lymphocyte-mediated killing. Perforin-induced pore formation.
    Krähenbühl O; Tschopp J
    Immunol Today; 1991 Nov; 12(11):399-402; discussion 403. PubMed ID: 1786073
    [No Abstract]   [Full Text] [Related]  

  • 26. Killing by cytotoxic T cells and natural killer cells: multiple granule serine proteases as initiators of DNA fragmentation.
    Trapani JA; Smyth MJ
    Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():201-8. PubMed ID: 8349302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
    Tschopp J; Masson D; Stanley KK
    Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-killer cell-specific transcription factors silence the perforin promoter.
    Zhang Y; Lichtenheld MG
    J Immunol; 1997 Feb; 158(4):1734-41. PubMed ID: 9029110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes.
    Lowin B; Mattman C; Hahne M; Tschopp J
    Int Immunol; 1996 Jan; 8(1):57-63. PubMed ID: 8671589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
    Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
    Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
    Cesano A; Visonneau S; Clark SC; Santoli D
    J Immunol; 1993 Sep; 151(6):2943-57. PubMed ID: 8104216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
    J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential contribution of Fas- and perforin-mediated mechanisms to the cell-mediated cytotoxic activity of naive and in vivo-primed intestinal intraepithelial lymphocytes.
    Corazza N; Müller S; Brunner T; Kägi D; Mueller C
    J Immunol; 2000 Jan; 164(1):398-403. PubMed ID: 10605035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of cytolysis by complement and by cytolytic lymphocytes.
    Podack ER
    J Cell Biochem; 1986; 30(2):133-70. PubMed ID: 2422185
    [No Abstract]   [Full Text] [Related]  

  • 36. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.
    Kägi D; Vignaux F; Ledermann B; Bürki K; Depraetere V; Nagata S; Hengartner H; Golstein P
    Science; 1994 Jul; 265(5171):528-30. PubMed ID: 7518614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple mechanisms of lymphocyte-mediated killing.
    Young JD; Liu CC
    Immunol Today; 1988 May; 9(5):140-4. PubMed ID: 3076768
    [No Abstract]   [Full Text] [Related]  

  • 39. A calcium- and perforin-independent pathway of killing mediated by murine cytolytic lymphocytes.
    Young JD; Clark WR; Liu CC; Cohn ZA
    J Exp Med; 1987 Dec; 166(6):1894-9. PubMed ID: 3500267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.